Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Deepak K. Dalvie"'
Autor:
Deepak K. Dalvie, Bernard Testa
Publikováno v:
Burger's Medicinal Chemistry and Drug Discovery. :1-139
Publikováno v:
Chemical Research in Toxicology. 14:1139-1162
Autor:
Andrew V, Stachulski, Thomas A, Baillie, B Kevin, Park, R Scott, Obach, Deepak K, Dalvie, Dominic P, Williams, Abhishek, Srivastava, Sophie L, Regan, Daniel J, Antoine, Christopher E P, Goldring, Alvin J L, Chia, Neil R, Kitteringham, Laura E, Randle, Hayley, Callan, J Luis, Castrejon, John, Farrell, Dean J, Naisbitt, Martin S, Lennard
Publikováno v:
Medicinal research reviews. 33(5)
The decline in approval of new drugs during the past decade has led to a close analysis of the drug discovery process. One of the main reasons for attrition is preclinical toxicity, frequently attributed to the generation of protein-reactive drug met
Autor:
Deepak K. Dalvie, Wayne K. Anderson
Publikováno v:
Journal of Heterocyclic Chemistry. 30:1533-1536
The title compounds were synthesized from 3-[bis(2-hydroxyethyl)- amino]quinolin-2(1H)-one (11a) and 3-[bis(2-hydroxyethyl)amino]- pyridin-2(1H)-one (18) respectively. The preparation involved a tandem chlorination/cyclization reaction
Autor:
Wayne K. Anderson, Deepak K. Dalvie
Publikováno v:
ChemInform. 25
The title compounds were synthesized from 3-[bis(2-hydroxyethyl)- amino]quinolin-2(1H)-one (11a) and 3-[bis(2-hydroxyethyl)amino]- pyridin-2(1H)-one (18) respectively. The preparation involved a tandem chlorination/cyclization reaction
Autor:
Sabrina X. Zhao, Deepak K. Dalvie, Joan M. Kelly, John R. Soglia, Kosea S. Frederick, Evan B. Smith, R. Scott Obach, Amit S. Kalgutkar
Publikováno v:
Chemical Research in Toxicology; Nov2007, Vol. 20 Issue 11, p1649-1657, 9p